1. Home
  2. IMMR vs NYXH Comparison

IMMR vs NYXH Comparison

Compare IMMR & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$6.44

Market Cap

229.4M

Sector

Technology

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$4.63

Market Cap

188.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMR
NYXH
Founded
1993
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.4M
188.1M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
IMMR
NYXH
Price
$6.44
$4.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$12.25
$12.67
AVG Volume (30 Days)
689.7K
41.8K
Earning Date
12-19-2025
11-13-2025
Dividend Yield
4.65%
N/A
EPS Growth
57.07
N/A
EPS
2.04
N/A
Revenue
$163,133,000.00
$6,616,215.00
Revenue This Year
$988.71
$79.25
Revenue Next Year
$109.72
$297.08
P/E Ratio
$3.16
N/A
Revenue Growth
338.21
10.96
52 Week Low
$5.65
$4.35
52 Week High
$9.37
$11.87

Technical Indicators

Market Signals
Indicator
IMMR
NYXH
Relative Strength Index (RSI) 42.03 48.89
Support Level $6.42 $4.69
Resistance Level $7.09 $4.93
Average True Range (ATR) 0.19 0.18
MACD -0.04 0.02
Stochastic Oscillator 6.16 56.82

Price Performance

Historical Comparison
IMMR
NYXH

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: